Latest 20-F annual reports
NYSE
Gold Fields Limited's 20-F filing reveals a year of operational hurdles and strategic shifts, setting the stage for future growth and sustainability initiatives.
NASDAQ
Gilat Satellite Networks updates its share incentive plan and details the acquisition of Stellar Blu Solutions in its latest 20-F filing.
NASDAQ
ALLT
Allot LTDAllot Ltd. reports a slight revenue decrease in 2024, pivoting towards security-first strategy with unified business unit.
NASDAQ
Kornit Digital files its annual report on Form 20-F, detailing its financial performance for the year ended December 31, 2024, and outlining key business strategies and risk factors.
NASDAQ
20-F: IceCure Medical Reports FY2024 Results, Faces Going Concern Uncertainty Amidst Regulatory Review
IceCure Medical's FY2024 annual report reveals ongoing losses and doubts about its ability to continue as a going concern, while awaiting a critical FDA decision on its ProSense system for breast cancer treatment.
NASDAQ
20-F: IceCure Medical Reports FY2024 Results, Faces Going Concern Uncertainty Amidst Regulatory Review
IceCure Medical's FY2024 annual report reveals ongoing losses and doubts about its ability to continue as a going concern, while awaiting a critical FDA decision on its ProSense system for breast cancer treatment.
NYSE
KNOT Offshore Partners LP files its 20-F report, detailing its financial performance and operational activities for the fiscal year ending December 31, 2024.
NASDAQ
IMTX
Immatics NVImmatics N.V. reports its 2024 financial results and provides an update on its clinical development programs, showcasing progress in TCR-based immunotherapies.
NASDAQ
TSAT
Telesat CORP20-F: Telesat Reports FY2024 Results, Navigates Challenges Amidst Lightspeed Constellation Development
Telesat's FY2024 results reveal a net loss due to foreign exchange impacts and revenue decline, while the company progresses with its Lightspeed constellation, securing significant funding.
NYSE
AEG
Aegon LTDAegon Ltd. delivered on its 2024 financial guidance, increasing dividends and executing share buybacks, while advancing its strategic transformation focused on growth markets in the US and UK.
NYSE
ASE Technology Holding Co., Ltd. releases its Form 20-F filing, detailing financial performance and operational activities for the fiscal year ended December 31, 2024.
NASDAQ
ALVO
AlvotechAlvotech's 2024 annual report reveals increased product revenue but also significant net losses, highlighting the challenges of biosimilar development and commercialization.
NASDAQ
iQIYI's 20-F filing reveals a year of strategic adjustments and financial resilience amidst complex regulatory and competitive pressures in the Chinese online entertainment market.
NYSE
Brookfield Wealth Solutions files its 20-F, highlighting key financial data and strategic developments for the fiscal year ended December 31, 2024.
NASDAQ
uCloudlink Group Inc. releases its 2024 annual report, detailing financial results, strategic initiatives, and key risk factors including regulatory challenges in mainland China.
NYSE
CANG
Cango INCCango Inc. reports its 20-F filing for the fiscal year ended December 31, 2024, detailing its expansion into crypto mining and providing an overview of its financial performance and corporate structure.
NYSE
Andina Bottling Co Inc files its 20-F report for the fiscal year ended December 31, 2024, detailing its financial performance and operational activities.
NASDAQ
20-F: TAT Technologies Unveils 2022 Stock Option Plan to Incentivize Employees and Boost Stockholder Value
TAT Technologies introduces a new stock option plan aimed at attracting, retaining, and rewarding eligible employees, consultants, and non-employee directors, thereby aligning their interests with those of the company's stockholders.
NASDAQ
AUDC
Audiocodes LTDAudioCodes releases its 20-F filing, detailing financial performance, risk factors, and strategic developments amidst global economic and geopolitical challenges.
NASDAQ
20-F: CollPlant Biotechnologies Reports Annual Results, Highlights Progress in Regenerative Medicine
CollPlant Biotechnologies Ltd. releases its annual report for the year ended December 31, 2024, showcasing advancements in its rhCollagen-based regenerative and aesthetic medicine programs.
NASDAQ
RDCM
Radcom LTDRADCOM Ltd. files its 20-F form, reporting an increase in revenue and net income for the fiscal year ended December 31, 2024, and outlines its business strategy and risk factors.
NYSE
Himalaya Shipping Ltd.'s 20-F filing reveals increased operating revenues and net income for the fiscal year ended December 31, 2024, driven by fleet expansion and higher charter rates.
NASDAQ
ECARX Holdings Inc. releases its annual report on Form 20-F, providing a comprehensive overview of the company's performance, financial condition, and future strategies for the fiscal year ended December 31, 2024.
NYSE
20-F: Prudential PLC Releases 2024 20-F Filing, Highlights Strategic Progress and Strong Capital Position
Prudential PLC's 2024 filing showcases strategic advancements and a robust capital foundation, positioning the company for future growth in Asia and Africa.
AMEX
MYND
Myndai, INCMynd.ai's 2024 20-F filing reveals a year of declining revenue and a net loss, influenced by reduced customer demand and strategic shifts.
NYSE
20-F: Rentokil Initial PLC Releases 20-F Filing, Highlights Strategic Priorities and Financial Performance
Rentokil Initial PLC's 20-F filing highlights the company's strategic priorities, financial performance, and risk management for the fiscal year ended December 31, 2024.
JBSAY
Jbs SAJBS S.A.'s 20-F filing reveals a robust financial year with increased net revenue and a return to net income, driven by strategic acquisitions and operational efficiencies.
NYSE
Navigator Holdings Ltd. releases its Form 20-F filing, detailing its financial performance for the year ended December 31, 2024, and outlining strategic initiatives and risk factors.
NASDAQ
20-F: Perion Network Updates Executive Compensation Policy and Discloses Financial Data in 20-F Filing
Perion Network Ltd. updates its executive compensation policy and provides financial data in its annual 20-F filing, emphasizing alignment with shareholder value and long-term goals.
NASDAQ
WRD
Weride INCWeRide Inc.'s latest 20-F filing provides a detailed overview of the company's strategic direction, financial performance, and operational activities within the rapidly evolving autonomous driving industry.